Clinical Trial Update: Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and preliminary efficacy of combining vemurafenib with high-dose interferon alfa-2b in melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Intron A (interferon alfa-2b)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: John Kirkwood | Conditions: Melanoma | Phase 1 | Status: COMPLETED